Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2020 Jun 11;295(32):11056–11067. doi: 10.1074/jbc.RA120.013751

The functional role of the αM4 transmembrane helix in the muscle nicotinic acetylcholine receptor probed through mutagenesis and coevolutionary analyses

Mackenzie J Thompson 1, Jaimee A Domville 1, John E Baenziger 1,*
PMCID: PMC7415963  PMID: 32527728

Abstract

The activity of the muscle-type Torpedo nicotinic acetylcholine receptor (nAChR) is highly sensitive to lipids, but the underlying mechanisms remain poorly understood. The nAChR transmembrane α-helix, M4, is positioned at the perimeter of each subunit in direct contact with lipids and likely plays a central role in lipid sensing. To gain insight into the mechanisms underlying nAChR lipid sensing, we used homology modeling, coevolutionary analyses, site-directed mutagenesis, and electrophysiology to examine the role of the α-subunit M4 (αM4) in the function of the adult muscle nAChR. Ala substitutions for most αM4 residues, including those in clusters of polar residues at both the N and C termini, and deletion of up to 11 C-terminal residues had little impact on the agonist-induced response. Even Ala substitutions for coevolved pairs of residues at the interface between αM4 and the adjacent helices, αM1 and αM3, had little effect, although some impaired nAChR expression. On the other hand, Ala substitutions for Thr422 and Arg429 caused relatively large losses of function, suggesting functional roles for these specific residues. Ala substitutions for aromatic residues at the αM4-αM1/αM3 interface generally led to gains of function, as previously reported for the prokaryotic homolog, the Erwinia chrysanthemi ligand-gated ion channel (ELIC). The functional effects of individual Ala substitutions in αM4 were found to be additive, although not in a completely independent manner. Our results provide insight into the structural features of αM4 that are important. They also suggest how lipid-dependent changes in αM4 structure ultimately modify nAChR function.

Keywords: nicotinic acetylcholine receptor (nAChR), pentameric ligand-gated ion channel (pLGIC), lipid–protein interactions, M4 transmembrane helix, transmembrane domain, channel gating, GLIC, ELIC, lipid sensing, membrane protein, coevolutionary analysis, Cys-loop receptor, mutagenesis, protein evolution, M4


Pentameric ligand-gated ion channels (pLGICs) are sensitive to a variety of allosteric modulators that act on the transmembrane domain (TMD), including lipids (15). In reconstituted membranes, the prototypic pLGIC, the Torpedo nicotinic acetylcholine receptor (nAChR), requires cholesterol and anionic lipids for optimal activity. These lipids promote function by stabilizing the nAChR in an agonist-activatable conformation and by enhancing transitions between conformational states (612). In the absence of both lipids, the nAChR adopts an uncoupled conformation that binds agonists but does not normally transition to open or desensitized states (1315).

Structures of the nAChR and other pLGICs place the fourth transmembrane α-helix (M4) of each subunit at the periphery of the TMD in contact with lipids, suggesting an important role for M4 in lipid sensing (1619). A lipid-sensing role for M4 is supported further by the observation that mutations along M4 influence channel function (2024). In addition, lipids bind to the interface between M4 and the adjacent TMD α-helices, M1 and M3, in several pLGIC structures (1, 2529).

Lipids likely influence pLGIC function by altering interactions between M4 and M1/M3 (30, 31). One model proposes that altered M4–M1/M3 interactions modulate contact between the M4 C terminus and the β6-β7 loop (the Cys loop in eukaryotic pLGICs), a structure at the interface between the extracellular domain (ECD) and TMD that plays an important role in translating agonist binding into channel gating (3235). This model is supported by the observation that a lipid bridges interactions between M4 and the β6-β7 loop/Cys loop in the prokaryotic Gloeobacter violaceus ligand-gated ion channel, GLIC, with mutations of implicated residues impairing both function and expression (36). The M4 C terminus is also important in the expression and/or function of the α4β2 nAChR, the 5-HT3A receptor, the ρ1 GABAA receptor, and a α7/5-HT3A receptor chimera (3740), and has been implicated in neurosteroid-induced potentiation of both the neuronal α4β2 nAChR and the GABAA receptor (41, 42). On the other hand, specific interactions between M4 and the β6-β7 loop/Cys loop are not critical to function in the Erwinia chrysanthemi ligand gated ion channel, ELIC, suggesting that distinct mechanisms underlie lipid sensing in different pLGICs (see, for example, reference 43).

To better understand lipid sensing, we and others have used Ala-scanning mutagenesis to identify residues in M4 that play an important role in function (36, 39, 4447). Whereas these studies have been informative, they have all focused on homomeric pLGICs. An intriguing question that remains to be addressed is how the M4 α-helix from different subunits of a heteromeric pLGIC influences channel function and, thus, participates in lipid sensing. As a first step to addressing this question, we use here a combination of mutagenesis, evolutionary couplings, and two-electrode voltage clamp electrophysiology to explore the functional role of M4 from the α subunit (αM4) of the human adult muscle nAChR (α2βεδ). Our data reveal several unique features regarding the role of αM4 in function and provide a structural basis for understanding the lipid sensitivity of the muscle-type nAChR.

Results

Structural models of the human muscle α subunit

To properly interpret functional data derived from mutations in αM4 of the human adult muscle nAChR, a 3D structure that accurately defines the interactions that occur between αM4 and both αM1/αM3 and lipids is required. In the absence of such a structure, we first generated homology models based on the 4-Å-resolution apo structure of the Torpedo muscle-like nAChR (referred to as the 2BG9 Torpedo model), a revised Torpedo nAChR structure with a corrected sequence register in αM2/αM3, and a 3.3-Å-resolution nicotine-bound structure of the neuronal α3β4 nAChR (28, 48, 49). After the first submission of this work, an α-bungarotoxin-bound structure of the Torpedo nAChR was solved at 2.7-Å resolution (29). The new 6UWZ Torpedo structure reveals several novel features relevant here, including a corrected register in the fitting of the amino acid sequence into αM2/αM3 (50), a short αMX helix at the periphery of the αM4 N terminus, and an αM4 helix that is both contiguous with the intracellular αMA helix and rotated about its long axis to define different side-chain projections toward both αM1/αM3 and lipids. The rotation of αM4 is surprising, because five residues (Cys412, Met415, Cys418, Thr422, and Val425) that are labeled by the lipophilic photoreactive probe 3-trifluoromethyl-3-(m-[125I]iodophenyl)diazirine ([125I]-TID) and that define the αM4-lipid interface in the Torpedo 2BG9 structure (Fig. S1) (51) now project toward αM1/αM3. Whereas the positions of these residues in the new 6UWZ Torpedo structure are difficult to reconcile with the [125I]-TID labeling, they are supported by the structures of other neuronal nAChRs (52, 53) as well as by an identified interaction that occurs between αM1 Ser226 and αM4 Thr422 during channel function (24, 43). The hydrogen bond donor/acceptor distances between Ser226 and Thr422 are 11.1 and 7.1 Å in the 2BG9 and 6UWZ Torpedo structures, respectively. Thus, the new 6UWZ Torpedo structure requires a smaller reorientation of αM1/αM4 upon channel gating to bring Ser226 and Thr422 in close contact.

Note that the 2BG9 Torpedo structure was solved from cryoelectron microscopic images obtained from native Torpedo synaptosomes, whereas the 6UWZ Torpedo structure was solved from images obtained using nAChRs that were detergent solubilized from native Torpedo membranes, affinity purified, and then reconstituted into lipid nanodiscs. Given the high resolution of the 6UWZ Torpedo structure and structures of other neuronal nAChRs, we reinterpreted our mutagenesis data primarily in terms of a homology model based on the 6UWZ Torpedo structure (referred to as the 6UWZ Torpedo model), as shown in Fig. 1 and 4. Given the strength of the [125I]-TID labeling data, however, we considered a speculative possibility that αM4 undergoes a reorientation during solubilization/affinity purification/nanodisc reconstitution and, thus, have taken into account the orientation of αM4 defined in the 2BG9 Torpedo model.

Figure 1.

Figure 1.

Structure of the human αM4. A side view of the 2.7-Å cryo-EM structure of the Torpedo nAChR (PDB entry 6UWZ) is shown on the left. A zoomed-in view of the TMD of a human αM4 homology model, based on the 6UWZ structure, is shown on the right in two different orientations. Side chains are shown in ball and stick representation colored according to residue type: aromatic, yellow; polar/hydrogen bonding, green; positive, blue; negative, red; aliphatic, tan). Sequences of the M1, M3, and M4 helices from the human α1 nAChR are shown along the top with the helical regions boxed.

Figure 4.

Figure 4.

Comparison of the αM4 Ala scan heat map for the nAChR to those of GLIC and ELIC. The changes in EC50 values resulting from Ala mutation of each residue on M4 is heat mapped onto the structure for GLIC (PDB entry 4HFI) (A), nAChR (6UWZ Torpedo model) (B), and ELIC (homology model based on the GLIC structure) (C). Residues on M4 are represented as spheres colored according to the magnitude of the change in EC50. The scale runs between a 10-fold gain of function (red) and a 10-fold loss of function (blue), with no change in function shown as white. A mutant that gave no functional expression is shown in black, whereas a mutant that drastically altered desensitization kinetics is shown in dark gray.

A coevolutionary map of αM4–αM1/αM3 interactions

We used a coevolutionary approach to test further our two homology models and to identify potential interactions at the αM4–αM1/αM3 interface that play a role in channel function. In the coevolutionary approach, primary amino acid sequences of related proteins across the evolutionary timeline are aligned to identify pairs of residues that have coevolved. A probability score is given to every pair of residues in the sequence, with each probability score related to the proportion of sequences in which that residue pair has evolved together through the evolutionary timeline. This approach has been shown to successfully predict residue pairs in close physical proximity in a variety of proteins (54, 55).

Nine coevolved pairs with probability scores of greater than 90% were identified at the αM4–αM1/αM3 interface: four pairs at the αM1-αM4 interface (Ile219/Val425 [100%], Gly230/Leu411 [99.6%], Phe233/Phe414 [99.8%], and Tyr234/Leu411 [100%]) and five at the αM3-αM4 interface (Tyr277/Thr422 [97.0%], Phe280/Gly421 [100%], Thr281/Cys418 [100%], Phe284/Val417 [98.5%], and Thr298/Met406 [99.5%]). Only one residue, Thr133, in the Cys loop was found to have coevolved to some extent with a residue on αM4, Val413, but the probability score for the Thr133/Val413 pair is only 14.7%, suggesting that interactions between αM4 and the Cys-loop have not evolved a conserved role in muscle nAChR function.

Each of the four coevolved pairs of residues at the αM1-αM4 interface are relatively close to each other in both homology models, although Ile219/Val425 and Phe233/Phe414 are slightly closer in the 2BG9 Torpedo model, whereas Gly230/Leu411 and Tyr234/Leu411 are closer in the 6UWZ Torpedo model (Fig. 2 and Table S1). In contrast, the 6UWZ Torpedo model places four of the five coevolved pairs of residues at the αM3-αM4 interface in much closer proximity than the 2BG9 Torpedo model. The large distance between coevolved pairs of residues at the αM3-αM4 interface in the Torpedo 2BG9 model provides further evidence that there is an error in the register of the amino acid sequence in both αM2 and αM3, as confirmed in the 6UWZ Torpedo structure.

Figure 2.

Figure 2.

Coevolved residues on αM4 and αM1 or αM3. Coevolved residues on αM4-αM1 (A and B) and αM4-αM3 (C and D) are mapped onto the 2BG9 Torpedo (A and C) and the 6UWZ Torpedo (B and D) homology models of the human muscle α subunit. Each panel shows a top view of the TMD from the extracellular surface (top) and a side view from within the membrane (bottom). Residues are shown as ball and stick representation and colored according to the coevolved residue pairs: Ile219-Val425, brown; Gly230-Leu411, cyan; Phe233-Phe414, purple; Tyr234-Leu411, cyan; Tyr277-Thr422, dark blue; Phe280-Gly421, red; Thr281-Cys418, green; Phe284-Val417, yellow; and Thr298-Met406, black.

Ala scan of αM4

To probe the role of αM4 in nAChR function, we first generated Ala mutations at every position along αM4 and examined the functional effects of these mutations using two-electrode voltage clamp electrophysiology. Given the uncertainty of our original homology models, we were generous in the choice of residues that were mutated. In total, 36 Ala mutations were generated, starting at Trp399 and ending at Gly437.

The WT human adult muscle nAChR expresses robustly in Xenopus oocytes and responds in a concentration-dependent manner to acetylcholine with an EC50 of 7.61 ± 1.25 μm (n = 50) (Fig. 3). All 36 αM4 Ala mutants expressed, with the resulting EC50 values for the measured dose responses of each mutant, are summarized in Table 1. Although each measured EC50 value reflects a weighted average of all rate constants associated with both agonist binding/dissociation and channel opening/closing, the studied mutations are distant from the agonist binding site. Observed changes in EC50 likely reflect primarily changes in the opening/closing rate constants (i.e. channel gating), as opposed to effects on agonist binding/dissociation (i.e. agonist affinity) (24, 56). Note that changes in the rates of desensitization can also influence the measured EC50 values, although the mutants investigated here have, at most, subtle effects on desensitization rates (Fig. 3). The reported changes or lack of reported changes in EC50 values do not correlate with altered rates of desensitization. Regardless, we have presented concentration-dependent whole-cell trace electrophysiology recordings for a comprehensive set of mutations in Fig. S2.

Figure 3.

Figure 3.

Functional effects of Ala substitutions for residues on αM4. Representative two-electrode voltage clamp whole-cell responses to different concentration traces are shown for select mutations. Dose-response relationships for select mutations are plotted on the bottom right.

Table 1.

Functional effects of Ala mutations on residues within αM4

Mutation Dose responsea
EC50m) Hill slope n
WT 7.61 ± 1.25 1.70 ± 0.47 50
G437A 6.12 ± 0.87 1.58 ± 0.43 9
Q436A 8.29 ± 0.73 1.94 ± 0.14 13
Q435A 8.07 ± 0.51 2.03 ± 0.12 13
N434A 8.09 ± 0.68 1.94 ± 0.12 11
L433A 10.3 ± 1.1 1.93 ± 0.14 12
E432A 8.83 ± 0.62 1.92 ± 0.13 11
I431A 8.70 ± 0.64 1.85 ± 0.19 10
L430A 8.63 ± 1.30 1.72 ± 0.17 10
R429A 40.0 ± 9.5b 1.09 ± 0.12 10
G428A 6.15 ± 0.54 1.66 ± 0.28 9
A427 WT WT
F426A 2.02 ± 0.64b 1.80 ± 0.76 11
V425A 4.30 ± 0.51b 1.89 ± 0.28 10
A424 WT WT
L423A 5.80 ± 0.87 2.54 ± 0.66 10
T422A 31.2 ± 9.0b 1.40 ± 0.12 10
G421A 10.0 ± 1.2 1.96 ± 0.26 9
I420A 5.97 ± 0.94 2.71 ± 0.33 10
I419A 6.58 ± 1.08 2.15 ± 0.32 10
C418A 10.6 ± 2.85b 1.82 ± 0.33 9
V417A 7.71 ± 1.35 1.94 ± 0.11 10
L416A 7.11 ± 0.77 2.01 ± 0.09 10
M415A 12.5 ± 3.1b 1.61 ± 0.27 10
F414A 4.47 ± 0.82b 1.76 ± 0.34 10
V413A 7.24 ± 1.09 2.20 ± 0.26 10
G412A 6.77 ± 1.09 1.54 ± 0.31 9
L411A 9.86 ± 2.44b 2.35 ± 0.40 13
L410A 5.21 ± 1.08b 2.06 ± 0.59 21
I409A 8.22 ± 1.91 2.05 ± 0.51 10
H408A 10.1 ± 1.2b 1.80 ± 0.27 10
D407A 4.97 ± 0.45b 3.12 ± 0.78 11
M406A 8.37 ± 0.84 1.70 ± 0.21 14
V405A 7.76 ± 1.06 2.03 ± 0.39 10
M404A 8.05 ± 0.73 2.14 ± 0.40 10
A403 WT WT
V402A 7.91 ± 0.38 2.05 ± 0.13 9
Y401A 9.86 ± 0.73b 1.75 ± 0.48 11
K400A 12.9 ± 2.6b 1.89 ± 0.63 15
W399A 8.90 ± 0.58 2.51 ± 0.41 10

a Measurements were performed 1–4 days after cRNA injection (Vhold ranging from −20 to −80 mV). Error values are represented as standard deviations.

b p < 0.001 relative to WT via one-way ANOVA followed by Dunnett's post hoc test.

The changes in EC50 value for every mutant relative to the WT are heat mapped onto αM4 in Fig. 4, where the αM4 heat map is compared with similar heat maps generated for the prokaryotic homologs, GLIC and ELIC. Our initial discussion focuses on comparisons of the αM4 Ala scan with those of GLIC and ELIC, because all data sets were recorded under comparable conditions (36). The comparisons are broadened to include other pLGICs in the Discussion.

Of the 36 Ala mutations, 13 lead to statistically significant changes in the EC50 values relative to the WT, although two of these (Lys400 and Tyr401) likely should be considered as being part of αMA and project toward the cytoplasm (Fig. 1). The proportion of mutations on αM4 (13 of 36) that lead to significant changes in the measured EC50 values is lower than that in either GLIC (17 of 26) or ELIC (26 of 29), likely reflecting the fact that the α subunit and, thus, each mutation, is present only twice per nAChR pentamer, whereas each mutation in both GLIC and ELIC is repeated in all five subunits. Also, a larger proportion of the generated substitutions in the human αM4 are conservative changes from a larger to a smaller aliphatic side chain (18 mutations) or from Gly to Ala (4 mutations).

On the other hand, even though fewer Ala mutations in αM4 lead to statistically significant changes in the measured EC50 values than in either GLIC or ELIC, three mutations, R429A, T422A, and F426A, lead to changes in EC50 values (5.3-fold, 4.1-fold, and 3.8-fold, respectively) that are similar in magnitude to the largest changes in EC50 values observed with M4 Ala substitutions in GLIC/ELIC, despite the fact that the αM4 mutations occur in only two of the five subunits. In fact, only a few Ala mutations in GLIC/ELIC lead to comparable changes in EC50 values. To put this observation in perspective, if the effects of the R429A mutation were independent and conserved across all five subunits, then the simultaneous Ala substitution for all five residues would lead to a 60-fold change in the measured EC50 value, a value greater than that of any functional change observed with Ala mutations in the homopentameric GLIC and ELIC. This calculation highlights the functional sensitivity of the human adult muscle nAChR to mutations along αM4.

Finally, the nature and pattern of the observed changes in the EC50 values have both similarities with and differences to those observed in GLIC and ELIC. In αM4, Ala mutations lead to a mix of both loss (8/13)- and gain (5/13)-of-function phenotypes. In contrast, the majority of the Ala mutations (15 of 17) of M4 residues in GLIC led to loss-of-function phenotypes, whereas all 26 Ala mutations in M4 of ELIC led to gain-of-function phenotypes. In addition, the vast majority of the Ala substitutions that influence GLIC function, and those with the largest gain-of-function phenotypes in ELIC, are located at the M4–M1/M3 interface. Similar to GLIC and ELIC, the 6UWZ Torpedo model places most (8/13) of the changes in function, including the most impactful, at the αM4–αM1/αM3 interface. In contrast, the 2BG9 Torpedo model places the latter residues at the αM4–lipid interface, with several being directly labeled by [125I]-TID (51).

Polar residues at the N and C termini of αM4

αM4 exhibits clusters of polar/charged residues at both its N (Asp407 and His408) and C (Arg429, Glu432, Asn434, Gln435, and Gln436) termini (Fig. 1) that could form functionally important interactions with either lipids or adjacent residues in the TMD and/or ECD. At the αM4 N terminus, Asp407 projects toward Lys242 on the αM1-αM2 loop (6UWZ Torpedo model) or toward Thr237 on M1 (2BG9 Torpedo model), whereas His408 projects toward lipids, forming a hydrogen with the phosphate of a bound lipid in one α subunit of the 6UWZ Torpedo structure. Regardless, the Ala substitution of either residue has little effect (1.3-fold gain and 1.5-fold loss of function, respectively) on the measured EC50 value, suggesting that neither residue forms interactions that are critical for expression or function.

At the αM4 C terminus, the 6UWZ Torpedo model projects Arg429 and Glu432 toward His134 of the Cys-loop with the remaining polar residues (Asn434, Gln435, and Gln436) unresolved. In contrast, the 2BG9 Torpedo model projects Glu432 and Gln435 toward Phe137 of the Cys-loop, with Arg429, Asn434, and Gln436 facing the lipid. Surprisingly, Ala substitutions of Glu432, Asn434, Gln435, and Gln436 have no effect on channel function, suggesting that none of these residues form functionally significant interactions that are critical to expression or function. On the other hand, R429A leads to a relatively large 5.3-fold loss of function, suggesting an important functional interaction between αM4 and the Cys-loop. Despite this important result, the interpretation that Arg is functionally important is clouded by the lack of an effect on the measured EC50 value upon deletion of this residue, as discussed below.

The hydrophobic core of αM4

The central core of αM4 is formed mainly by aliphatic residues, although these are interspersed with two aromatic residues, Phe414 and Phe426, and the potential hydrogen-bonding residues, Cys418 and Thr422. The conservative Ala substitution of the five large aliphatic residues in the hydrophobic core of αM4, Leu410, Leu411, M415, and Val425, each leads to a statistically significant change in the EC50 value, although all changes are less than 2-fold. The Ala substitutions for the two aromatic residues, Phe414 and Phe426, lead to 1.7-fold and 3.8-fold gains of function, respectively, suggesting detrimental effects on function. The latter are of particular interest given the importance of aromatic interactions at the M4–M1/M3 interfaces in the folding and function of other pLGICs (31, 44). The functional roles of aromatic residues at the αM4–αM1/αM3 interface are explored in more detail below.

The Ala substitution of Thr422 leads to a relatively large 4.1-fold loss of function. Thr422 faces αM1 in the 6UWZ Torpedo model but projects tangentially to αM1 interacting with lipid in the 2BG9 Torpedo model. Consistent with our data showing a loss of function, single-channel measurements indicate that T422A in the mouse adult muscle nAChR leads to a 5-fold decrease in channel open times. In addition, a mutant cycle analysis suggests an interaction between Thr422 and the nearby αM1 Ser226 stabilizes the open state (43). Interestingly, although the adjacent C418A mutation leads to only a small 1.4-fold loss of function, C418W leads to a relatively large 16- to 25-fold gain of function and a congenital myasthenic syndrome (43, 57). Channel function in the adult muscle nAChR appears to be sensitive to the structure of residues in the vicinity of Thr422. This region of αM4 may be particularly responsive to changes in the surrounding lipid environment.

The αM4 C terminus

Previous studies with other pLGICs have highlighted a role for the M4 C terminus in function, possibly through interactions with the Cys-loop (36, 38, 39, 45). In contrast, Ala mutations of most residues at the αM4 C terminus that could interact with the Cys-loop or other structures in the ECD have little effect on the measured EC50 values, as discussed above, suggesting that such interactions are not critical in the muscle nAChR. To further probe the functional role of interactions between αM4 and the Cys-loop, we generated αM4 C-terminal deletions. Deleting up to four residues at the C terminus of αM4 has no effect on channel function (Table 2). Deleting from five to eleven residues leads to a gradual increase in the measured EC50 values corresponding to a gradual loss of function, but the maximal loss of function is only 3-fold despite a major disruption in the structure of αM4. Deleting twelve residues or the entire αM4 α-helix (data not shown) leads to a loss of functional expression. These data suggest that interactions between αM4 and the Cys-loop are not critical.

Table 2.

Functional effects of αM4 C-terminal deletionsa

Deletion(s) Dose responseb
EC50m) Hill slope n
WT:…LAVFAGRLIELNQQG 7.61 ± 1.25 1.70 ± 0.47 50
Δ1: …, LAVFAGRLIELNQQ 6.86 ± 0.86 2.66 ± 0.67 9
Δ2: …, LAVFAGRLIELNQ 6.37 ± 0.94 2.62 ± 0.54 9
Δ3: …, LAVFAGRLIELN 7.14 ± 1.09 2.36 ± 0.38 8
Δ4: …, LAVFAGRLIEL 8.49 ± 1.39 2.13 ± 0.44 8
Δ5: …, LAVFAGRLIE 11.8 ± 1.0c 1.65 ± 0.33 10
Δ6: …, LAVFAGRLI 12.3 ± 1.2c 1.59 ± 0.25 10
Δ7: …, LAVFAGRL 12.7 ± 1.7c 1.54 ± 0.15 10
Δ8: …, LAVFAGR 14.7 ± 2.6c 1.46 ± 0.29 10
Δ9: …, LAVFAG 14.9 ± 2.5c 1.77 ± 0.35 10
Δ10: …LAVFA 21.4 ± 4.2c 1.35 ± 0.12 10
Δ11: …LAVF 23.0 ± 5.0c 1.69 ± 0.36 10
Δ12: …LAV No currentd 8

a The shown sequences extend from Leu423 to Gly437.

b Measurements were performed 1–4 days after cRNA injection (Vhold ranging from −20 to −80 mV). Error values are represented as standard deviations.

c p < 0.001 relative to the WT via one-way ANOVA followed by Dunnett's post hoc test.

d No significant current was observed up to 4 days after cRNA injection.

Note that the deletion of nine C-terminal residues (Arg429 to Gly437) led to essentially no further change in the measured EC50 value than the deletion of eight C-terminal residues (Leu430 to Gly437), despite the fact that the R429A mutant leads to a relatively large 5.3-fold loss of function. The functional importance of Arg429 may only be evident in the presence of the adjacent C-terminal polar/anionic residues Glu432, Asn434, Gln435, and/or Gln436.

Aromatic residues at the αM4–αM1/αM3 interface

Given their importance in other pLGICs (30, 31, 39, 44, 46), we examined the functional role of aromatic residues at the αM4–αM1/αM3 interface in the nAChR (Fig. 5 and Table 3). In the intracellular leaflet of the bilayer, αM4 Phe414 interacts with αM1 Phe233 and αM3 Phe284 in the 6UWZ Torpedo model but is also close to αM1 Tyr234 in the 2BG9 Torpedo model. As noted, Ala mutation of Phe414 leads to a small 1.7-fold gain of function, whereas the F233A and F284A mutations lead to 2.9-fold and 1.6-fold gains of function, respectively. The F414A/F233A double mutant leads to a 7-fold gain of function, slightly more than what would be expected if the two mutations are independent and additive. These three bulky aromatic residues are detrimental to channel function and may sterically prevent optimal αM4–αM1/αM3 interactions, as is observed with aromatic residues at the M4–M1/M3 interface in ELIC.

Figure 5.

Figure 5.

Aromatic residues at the αM4–αM1/αM3 interface. Aromatic residues at the αM4–αM1/αM3 interface are shown in ball and stick representations and are colored yellow. The TMDs from the 2BG9 Torpedo (left) and 6UWZ Torpedo (right) models are shown in both top views from the extracellular surface (top) and side views from within the membrane (bottom).

Table 3.

Functional effects of mutating αM4–αM1/αM3 interfacial aromatics

Mutation Dose responsea
TMD α-helix EC50m) Hill slope n
WT 7.61 ± 1.25 1.70 ± 0.47 50
F225A αM1 0.71 ± 0.12b 1.57 ± 0.39 8
F227A αM1 6.51 ± 1.47 1.43 ± 0.16 8
F233A αM1 2.63 ± 0.31b 1.63 ± 0.20 9
Y234A αM1 No currentc No currentc 8
Y234L αM1 5.79 ± 0.72 2.20 ± 0.33 8
Y234F αM1 8.43 ± 2.03 1.66 ± 0.27 8
Y277A αM3 11.2 ± 1.97b 1.78 ± 0.58 8
F280A αM3 4.25 ± 1.00b 1.56 ± 0.29 8
F284A αM3 4.80 ± 0.75b 1.33 ± 0.21 9
F414A αM4 4.47 ± 0.82b 1.76 ± 0.34 10
F225A+F280A αM1+αM3 No currentc 8
F225A+F284A αM1+αM3 No currentc 8
F280A+F284A αM3+αM3 8.42 ± 2.98 1.45 ± 0.08 9
F225A+F280A+F284A αM1+αM3+αM3 No currentc 8
F233A+F414A αM1+αM4 1.08 ± 0.10b 2.21 ± 0.36 8

a Measurements were performed 1–4 days after cRNA injection (Vhold ranging from −20 to −80 mV). Error values are represented as standard deviations.

b p < 0.001 relative to the WT via one-way ANOVA followed by Dunnett's post hoc test.

c No significant current was observed up to 4 days after cRNA injection.

In contrast, the Ala mutant of Tyr234 does not express, although both Y234L and Y234F give nearly WT EC50 values, indicating that a bulky hydrophobic residue is required at this position for proper folding and/or function. Intriguingly, Tyr234 lies along the base of a lipid binding site in the 6UWZ structure, where it interacts extensively with a bound lipid and shapes the lipid binding site. The role of this putative lipid binding aromatic residue warrants further exploration.

In the extracellular leaflet of the bilayer, αM4 Phe426 projects toward αM3 Tyr277/Phe280 in the 6UWZ Torpedo model. As noted, F426A mutation leads to a relatively large 3.8-fold gain of function. In contrast, the two αM3 aromatic mutations had minimal effects, with Y277A and F280A leading to a 1.5-fold loss and a 1.8-fold gain of function, respectively. Even the double mutant, F280A/F284A, had little effect on the measured EC50 value.

We also probed the role of αM1 Phe225 on channel function, as our early models suggested that it projects toward aromatic residues located on αM3. The F225A mutant led to a relatively large 11-fold gain of function. Somewhat surprisingly, double aromatic mutants involving Phe225 (F225A/F280A and F225A/F284A), along with the triple αM3 aromatic mutant (Y277A/F280A/F284A), resulted in no functional expression. Note that in the new 6UWZ Torpedo model, Phe225 is oriented toward αM2, where it may sterically hinder movement of this gating helix as it transitions to the open state.

Functional role of coevolved residues at the αM4–αM1/αM3 interface

We used mutant cycles to test whether interactions between coevolved pairs of residues play a role in channel function. In a mutant cycle, the individual effects of mutating two potentially interacting residues are compared with the effect of the double mutant to assess whether the residues influence function independently or through a common mechanism; the latter would be the case if they were involved in a direct interaction. The independence of the functional effects is evaluated using a parameter, Ω (see Experimental procedures), where an Ω value of 1 indicates that the two mutations influence channel function independently, whereas Ω values of increasingly greater than or less than 1 indicate increasing degrees of mutual dependence. Although mutant cycles are ideally used when the rate constants for gating can be defined, this approach has proven informative at the whole-cell level (43, 58). We generally consider up to ∼2-fold changes in Ω values as being within the error limits of our measurements (58).

Both individual and double Ala mutations were created for each coevolved pair of residues at both the αM1-αM4 (Ile219/Val425, Gly230/Leu411, Phe233/Phe414, and Tyr234/Leu411) and αM3-αM4 interfaces (Tyr277/Thr422, Phe280/Gly421, Thr281/Cys418, Phe284/Val417, and Thr298/Met406) (Table S2). At the αM1-αM4 interface, the effects of the single and double mutations are all minimal, suggesting that these coevolved pairs do not play a critical role in either folding or function. Similar effects are also observed with Ala mutations of coevolved residues at the αM3-αM4 interface, except that T281A and T298A do not functionally express. In addition, although the Ala mutations of the evolutionarily coupled residues αM3 Tyr277 and αM4 Thr422 lead to 1.5-fold and 4.1-fold losses of function, respectively, the Y277A/T422A double mutant does not express. Although the latter findings lend further support to the hypothesis that Thr422 plays an important role in αM4 function, the collective data suggest that coevolved residues at the αM1–αM3/αM4 interface generally do not play a critical functional role.

The additivity of mutations along αM4

Finally, we asked whether the functional effects of Ala mutations along αM4 are additive. We first created two triple Ala mutants involving the three residues on αM4 that lead to relatively large losses of function (R429A [5.3-fold], T422A [4.1-fold], and L411A [1.3-fold]) and relatively large gains of function (F426A [3.8-fold], F414A [1.7-fold] and D407A [1.5-fold]). If each mutation impacts function via changes only to the local environment surrounding that residue, then we would expect the mutations to be independent and, thus, additive, leading to a 28-fold loss of function and a 10-fold gain of function, respectively. The R429A+T422A+L411A triple mutant led to only a 6-fold loss of function, close to 5 times less than expected (Table S3). Thus, the effects of these three mutations are not completely independent. Unfortunately, the F426A+F414A+D407A triple mutant gave no functional expression.

We next created two triple Ala mutants involving residues where the individual Ala mutations led to a mix of loss- and gain-of-function phenotypes. If the mutations are independent and, thus, additive, we would expect the triple mutants, F426A+M415A+H408A and R429A+F414A+D407A, to lead to a 2-fold gain of function and a 2-fold loss of function, respectively. The F426A+M415A+H408A triple mutant gave a 3-fold gain of function, suggesting that these three mutants influence function independently. In contrast, the R429A+F414A+D407A triple mutant did not give functional expression.

Discussion

The long-term goal of this work is to understand the mechanisms underlying the exquisite functional sensitivity of the muscle nAChR to its surrounding membrane environment. The M4 α-helix located at the lipid-exposed periphery of the transmembrane domain of each subunit plays a central role in lipid sensing. M4 likely translates changes in the surrounding membrane environment to altered channel function via its interactions with the adjacent transmembrane α-helices, M1 and M3, although the underlying pathway(s) remains unclear. An important first step in the elucidation of these pathways is to understand the functional role of the M4 α-helices in the different subunits of the α2βγδ (fetal) or α2βεδ (adult) pentamers. Here, we focused on the functional role of αM4 (i.e. M4 from the α subunit) from the human adult muscle nAChR.

We first examined the functional effects of Ala substitutions at each residue along the entire length of αM4 and found that the effects generally differ both quantitatively and qualitatively from those observed with M4 Ala mutations in other pLGICs, such as GLIC and ELIC. In the nAChR, only 13 of 36 substitutions in αM4 lead to statistically significant changes in the agonist-induced response, whereas a large majority of the Ala substitutions in GLIC (17 of 26) and ELIC (26 of 29) alter channel function. In the nAChR, Ala mutations in αM4 lead to a mix of both loss- and gain-of-function phenotypes, whereas in GLIC and ELIC the vast majority of M4 Ala mutations lead to either loss-of-function or gain-of-function phenotypes, respectively. In the nAChR and ELIC, Ala substitutions for aromatic residues at the αM4–αM1/αM3 interface generally lead to improved channel function, whereas similar mutations in GLIC lead to losses of function. Finally, although a smaller number of Ala substitutions in αM4 lead to changes in function, the magnitudes of the changes in function of the most impactful mutations are comparable with those observed in the homomeric GLIC and ELIC, even though the mutations in αM4 are repeated in only two of the five subunits.

Collectively, these results suggest that αM4 impacts channel function in a manner that differs from the functional impact of M4 in either GLIC or ELIC. In GLIC, aromatic residues on M1, M3, and M4 interact with each other, creating a tight, complementary network at the M4–M1/M3 interface. Ala substitutions to almost any of these residues lead to a reduction in or a complete loss of expression and/or function, with double aromatic substitutions being especially damaging. A tight, complementary aromatic interface between M4 and M1/M3 is not only essential for both folding and function but also leads to tighter interactions (than those in ELIC) that render GLIC functionally insensitive to its surrounding membrane environment (30, 44). A complex network of interacting aromatic residues at the M4–M1/M3 interface is also observed in anion-selective pLGICs (59), with Ala substitutions of aromatic residues in these pLGICs generally leading to losses in function and/or expression (44, 45).

In contrast, there are relatively few bulky aromatic residues at the M4–M1/M3 interface of ELIC, with Ala mutations of most residues leading to gains in function. Even double aromatic-to-Ala alterations are tolerated and lead to enhanced channel function. It appears that the bulky aromatic side chains prevent the M4–M1/M3 interactions that are required for optimal channel function. They also likely create a more malleable M4–M1/M3 interface that renders ELIC more sensitive to its surrounding membrane environment (30). In fact, increased dynamics in the C-terminal half of M4, which may only be possible in the absence of aromatic residues leading to strong M4–M1/M3 interactions, play a key role in lipid binding that shapes the agonist-induced response (27).

As in ELIC, the nAChR, along with other cation-selective pLGICs, such as the 5-HT3R and the neuronal α7 homopentameric nAChR, lacks the complex network of aromatic residues at the αM4–αM1/αM3 interface that is found in GLIC. In the α subunit of the muscle nAChR and the α7 nAChR, Ala mutations of aromatic residues at the M4–M1/M3 interface generally lead to modest gains in function (47). These bulky aromatic residues may prevent optimal M4–M1/M3 interactions for channel function. A more malleable αM4–αM1/αM3 may also contribute to the exquisite lipid sensitivity of the nAChR, as has been extensively characterized for the Torpedo homolog (5). On the other hand, Ala substitutions along M4 in 5-HT3AR either have no effect or lead to losses in expression and/or function (46).

In this context, it is important to note that the introduction of aromatic interactions at the M4–M1/M3 interface of ELIC to create the same complex network of aromatic interactions that occur in GLIC both leads to an enhancement in channel function and reduces the functional sensitivity of ELIC to lipids (30, 60). Whereas similar experiments have not been performed in the muscle nAChR, Trp residues have been introduced along αM4 in the Torpedo nAChR at positions originally thought, based on [125I]-TID labeling, to be exposed to lipids. Although most of these Trp substitutions were detrimental to folding and/or function (22, 61), three Trp substitutions now positioned at the αM4–αM1/αM3 interface in the 6UWZ Torpedo nAChR structure lead to relatively large gains of function. It is possible that the addition of an extra bulky aromatic residue at select positions along this interface in the Torpedo nAChR helps to create optimal interactions between αM4 and αM1/αM3 to enhance channel function. Further work is required to assess the effects of aromatic residues at this interface in both function and lipid sensing.

In contrast to ELIC, however, the αM4 Ala-scan suggests that two residues, Arg429 and Thr422, both play a specific role in channel function, with the R429A and T422A mutations leading to relatively large loss-of-function phenotypes. It is possible that these residues contribute to specific interactions that ultimately drive how αM4 both influences function and senses its surrounding lipid environment. Similarly, in the homopentameric 5-HT3AR, three mutations along M4, D434A, Y441A, and W459A, lead to losses in expression and/or function. Of particular note, the D434A mutant does not express, possibly as a result of a critical interaction with Arg251 on the M1-M2 loop, which in turn forms a second hydrogen bond with the backbone of Leu244 on M2 (46). The equivalent mutation in the α7 nAChR, D446A, also does not express (47). In contrast, Ala mutation of the equivalent residue in αM4 of the muscle nAChR, Asp407, expresses robustly and produces a slight gain of function. It appears that the pathways by which M4 influences channel function differ in the 5-HT3AR, the neuronal α7 nAChR, and the α subunit of the muscle nAChR.

Finally, we assessed whether the effects of individual Ala mutations of residues located along αM4 are independent and, thus, additive. Although our data are limited, particularly as two of the four triple mutants do not express, they suggest that the effects of multiple mutations along M4 are additive, although not in a completely independent manner. In other words, although one of the triple mutants gives a loss of function larger than any of the individual mutations, the loss of function is less than expected if the individual effects were simply added together. These data suggest that a change in the orientation of the entire αM4 could lead to changes in a number of local interactions that add up to a significantly larger impact on channel gating. Similarly, lipid-dependent changes in the orientation of αM4 could alter nAChR function through the addition of multiple, subtle changes in local interactions at the αM4–αM1/αM3 interface. Further experiments are re-quired to both test this hypothesis and assess how the M4 α-helix from other subunits in the heteromeric muscle nAChR contribute to channel function.

Experimental procedures

Homology model and coevolutionary analysis

Homology models were created using the Swiss-Model online server (RRID:SCR_018123). Evolutionary couplings were determined using the online EVolutionary couplings server (RRID:SCR_018745).

Molecular biology and electrophysiology

Mutants were created from WT human α1, β1, δ, and ε nAChR sequences in the pcDNA3 vector using QuikChange™ site-directed mutagenesis kits (Agilent) and were verified by sequencing (43). The resulting vectors were linearized and capped cRNA produced by in vitro transcription using the mMESSAGE mMACHINE® T7 kit (Ambion).

Stage V–VI oocytes were injected with 5 ng of mutated α1 subunit cRNA along with 2.5 ng each of WT β1, δ, and ε subunit cRNA and allowed to incubate for 1 to 4 days at 16 °C, as described elsewhere (31). Whole-cell currents were measured in response to acetylcholine concentration jumps using a two-electrode voltage clamp (TEVC) apparatus (OC-725C oocyte clamp; Holliston, MA) in the presence of 1 μm atropine to prevent the activation of endogenous calcium-activated chloride channels via muscarinic acetylcholine receptors. Whole-cell currents were recorded in HEPES buffer (96 mm NaCl, 2 mm KCl, 1.8 mm BaCl2, 1 mm MgCl2, and 10 mm HEPES, pH 7.3), with the transmembrane voltage clamped at voltages between −20 mV and −80 mV, depending on the levels of protein expression. Dose responses for each mutant were acquired from at least two different batches of oocytes. Each individual dose response was fit with a variable-slope sigmoidal dose-response curve. Plots were created using GraphPad Prism, and the individual EC50 values and Hill coefficients from each experiment were averaged to give the presented values ± standard deviations. For the presented dose-response curves, the individual dose responses were normalized, and then each data point was averaged. Curve fits of the averaged data are presented, with the error bars representing the standard errors. Statistical significance was tested using a one-way analysis of variance (ANOVA), followed by Dunnett's post hoc test.

EC50 values obtained from TEVC recordings were cast as mutant cycles:

Ω=EC50mut1,2×EC50WTEC50mut1×EC50(mut2)

where WT is the WT control, mut1 is the first mutant, mut2 is the second mutant, and mut1,2 is the double mutant.

Data availability

All data described here are available within the manuscript and supporting information.

Supplementary Material

Supporting Information

This article contains supporting information.

Author contributions—M. J. T. and J. E. B. conceptualization; M. J. T. and J. A. D. data curation; M. J. T. and J. A. D. formal analysis; M. J. T. visualization; M. J. T. and J. A. D. methodology; M. J. T. and J. E. B. writing-original draft; M. J. T. and J. E. B. writing-review and editing; J. E. B. supervision; J. E. B. funding acquisition; J. E. B. project administration.

Funding and additional information—This work was supported by a grant from the National Sciences and Engineering Research Council of Canada (113312) to J. E. B.

Conflict of interestThe authors declare that they have no conflicts of interest with the contents of this article.

Abbreviations—The abbreviations used are:
pLGIC
pentameric ligand-gated ion channel
ECD
extracellular domain
TMD
transmembrane domain
ELIC
Erwinia ligand-gated ion channel
GLIC
Gloeobacter ligand-gated ion channel
nAChR
nicotinic acetylcholine receptor
[125I]-TID
3-trifluoromethyl-3-(m-[125I]iodophenyl)diazirine
ANOVA
analysis of variance.

References

  • 1. Thompson M. J., and Baenziger J. E. (2020) Structural basis for the modulation of pentameric ligand-gated ion channel function by lipids. Biochim. Biophys. Acta 1862, 183304 10.1016/j.bbamem.2020.183304 [DOI] [PubMed] [Google Scholar]
  • 2. Nury H., Van Renterghem C., Weng Y., Tran A., Baaden M., Dufresne V., Changeux J.-P., Sonner J. M., Delarue M., and Corringer P.-J. (2011) X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature 469, 428–431 10.1038/nature09647 [DOI] [PubMed] [Google Scholar]
  • 3. Forman S. A., Chiara D. C., and Miller K. W. (2015) Anesthetics target interfacial transmembrane sites in nicotinic acetylcholine receptors. Neuropharmacology 96, 169–177 10.1016/j.neuropharm.2014.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Barrantes F. J. (2015) Phylogenetic conservation of protein–lipid motifs in pentameric ligand-gated ion channels. Biochim. Biophys. Acta 1848, 1796–1805 10.1016/j.bbamem.2015.03.028 [DOI] [PubMed] [Google Scholar]
  • 5. Baenziger J. E., Hénault C. M., Therien J. P. D., and Sun J. (2015) Nicotinic acetylcholine receptor–lipid interactions: mechanistic insight and biological function. Biochim. Biophys. Acta 1848, 1806–1817 10.1016/j.bbamem.2015.03.010 [DOI] [PubMed] [Google Scholar]
  • 6. Baenziger J. E., Morris M. L., Darsaut T. E., and Ryan S. E. (2000) Effect of membrane lipid composition on the conformational equilibria of the nicotinic acetylcholine receptor. J. Biol. Chem. 275, 777–784 10.1074/jbc.275.2.777 [DOI] [PubMed] [Google Scholar]
  • 7. daCosta C. J. B., Ogrel A. A., McCardy E. A., Blanton M. P., and Baenziger J. E. (2002) Lipid-protein interactions at the nicotinic acetylcholine receptor. A functional coupling between nicotinic receptors and phosphatidic acid-containing lipid bilayers. J. Biol. Chem. 277, 201–208 10.1074/jbc.M108341200 [DOI] [PubMed] [Google Scholar]
  • 8. Hamouda A. K., Sanghvi M., Sauls D., Machu T. K., and Blanton M. P. (2006) Assessing the lipid requirements of the Torpedo californica nicotinic acetylcholine receptor. Biochemistry 45, 4327–4337 10.1021/bi052281z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. daCosta C. J. B., Medaglia S. A., Lavigne N., Wang S., Carswell C. L., and Baenziger J. E. (2009) Anionic lipids allosterically modulate multiple nicotinic acetylcholine receptor conformational equilibria. J. Biol. Chem. 284, 33841–33849 10.1074/jbc.M109.048280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Criado M., Eibl H., and Barrantes F. J. (1984) Functional properties of the acetylcholine receptor incorporated in model lipid membranes. J. Biol. Chem. 259, 9188–9198 [PubMed] [Google Scholar]
  • 11. Fong T. M., and McNamee M. G. (1986) Correlation between acetylcholine receptor function and structural properties of membranes. Biochemistry 25, 830–840 10.1021/bi00352a015 [DOI] [PubMed] [Google Scholar]
  • 12. Criado M., Eibl H., and Barrantes F. J. (1982) Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry 21, 3622–3629 10.1021/bi00258a015 [DOI] [PubMed] [Google Scholar]
  • 13. Baenziger J. E., Ryan S. E., Goodreid M. M., Vuong N. Q., Sturgeon R. M., and DaCosta C. J. B. (2008) Lipid composition alters drug action at the nicotinic acetylcholine receptor. Mol. Pharmacol. 73, 880–890 10.1124/mol.107.039008 [DOI] [PubMed] [Google Scholar]
  • 14. daCosta C. J. B., Dey L., Therien J. P. D., and Baenziger J. E. (2013) A distinct mechanism for activating uncoupled nicotinic acetylcholine receptors. Nat. Chem. Biol. 9, 701–707 10.1038/nchembio.1338 [DOI] [PubMed] [Google Scholar]
  • 15. daCosta C. J. B., and Baenziger J. E. (2009) A lipid-dependent uncoupled conformation of the acetylcholine receptor. J. Biol. Chem. 284, 17819–17825 10.1074/jbc.M900030200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Antollini S. S., Xu Y., Jiang H., and Barrantes F. J. (2005) Fluorescence and molecular dynamics studies of the acetylcholine receptor γM4 transmembrane peptide in reconstituted systems. Mol. Membr. Biol. 22, 471–484 10.1080/09687860500367915 [DOI] [PubMed] [Google Scholar]
  • 17. Xu Y., Barrantes F. J., Luo X., Chen K., Shen J., and Jiang H. (2005) Conformational dynamics of the nicotinic acetylcholine receptor channel: a 35-ns molecular dynamics simulation study. J. Am. Chem. Soc. 127, 1291–1299 10.1021/ja044577i [DOI] [PubMed] [Google Scholar]
  • 18. Williamson P. T. F., Zandomeneghi G., Barrantes F. J., Watts A., and Meier B. H. (2005) Structural and dynamic studies of the γ-M4 trans-membrane domain of the nicotinic acetylcholine receptor. Mol. Membr. Biol. 22, 485–496 10.1080/09687860500370653 [DOI] [PubMed] [Google Scholar]
  • 19. Hénault C. M., Sun J., Therien J. P. D., daCosta C. J. B., Carswell C. L., Labriola J. M., Juranka P. F., and Baenziger J. E. (2015) The role of the M4 lipid-sensor in the folding, trafficking, and allosteric modulation of nicotinic acetylcholine receptors. Neuropharmacology 96, 157–168 10.1016/j.neuropharm.2014.11.011 [DOI] [PubMed] [Google Scholar]
  • 20. Li L., Schuchard M., Palma A., Pradier L., and McNamee M. G. (1990) Functional role of the cysteine 451 thiol group in the M4 helix of the γ subunit of Torpedo californica acetylcholine receptor. Biochemistry 29, 5428–5436 10.1021/bi00475a003 [DOI] [PubMed] [Google Scholar]
  • 21. Lee Y. H., Li L., Lasalde J., Rojas L., McNamee M., Ortiz-Miranda S. I., and Pappone P. (1994) Mutations in the M4 domain of Torpedo californica acetylcholine receptor dramatically alter ion channel function. Biophys. J. 66, 646–653 10.1016/S0006-3495(94)80838-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Lasalde J. A., Tamamizu S., Butler D. H., Vibat C. R. T., Hung B., and McNamee M. G. (1996) Tryptophan substitutions at the lipid-exposed transmembrane segment M4 of Torpedo californica acetylcholine receptor govern channel gating. Biochemistry 35, 14139–14148 10.1021/bi961583l [DOI] [PubMed] [Google Scholar]
  • 23. Bouzat C., Roccamo A. M., Garbus I., and Barrantes F. J. (1998) Mutations at lipid-exposed residues of the acetylcholine receptor affect its gating kinetics. Mol. Pharmacol. 54, 146–153 10.1124/mol.54.1.146 [DOI] [PubMed] [Google Scholar]
  • 24. Bouzat C., Barrantes F., and Sine S. M. (2000) Nicotinic receptor fourth transmembrane domain: hydrogen bonding by conserved threonine contributes to channel gating kinetics. J. Gen. Physiol. 115, 663–671 10.1085/jgp.115.5.663 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Bocquet N., Nury H., Baaden M., Le Poupon C., Changeux J.-P., Delarue M., and Corringer P.-J. (2009) X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 457, 111–114 10.1038/nature07462 [DOI] [PubMed] [Google Scholar]
  • 26. Laverty D., Desai R., Uchański T., Masiulis S., Stec W. J., Malinauskas T., Zivanov J., Pardon E., Steyaert J., Miller K. W., and Aricescu A. R. (2019) Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer. Nature 565, 516–520 10.1038/s41586-018-0833-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Hénault C. M., Govaerts C., Spurny R., Brams M., Estrada-Mondragon A., Lynch J. W., Bertrand D., Pardon E., Evans G. L., Woods K., Elberson B. W., Cuello L. G., Brannigan G., Nury H., Steyaert J., et al. (2019) A lipid site shapes the agonist response of a pentameric ligand-gated ion channel. Nat. Chem. Biol. 15, 1156–1164 10.1038/s41589-019-0369-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Gharpure A., Teng J., Zhuang Y., Noviello C. M., Walsh R. M., Cabuco R., Howard R. J., Zaveri N. T., Lindahl E., and Hibbs R. E. (2019) Agonist selectivity and ion permeation in the α3β4 ganglionic nicotinic receptor. Neuron 104, 501–511 10.1016/j.neuron.2019.07.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Rahman M., Teng J., Worrell B. T., Karlin A., Stowell M. H. B., Hibbs R. E., Rahman M., Teng J., Worrell B. T., Noviello C. M., Lee M., and Karlin A. (2020) Structure of the native muscle-type nicotinic receptor and inhibition by snake venom toxins. Neuron 106, 1–11 10.1016/j.neuron.2020.03.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Carswell C. L., Sun J., and Baenziger J. E. (2015) Intramembrane aromatic interactions influence the lipid sensitivities of pentameric ligand-gated ion channels. J. Biol. Chem. 290, 2496–2507 10.1074/jbc.M114.624395 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Carswell C. L., Hénault C. M., Murlidaran S., Therien J. P. D., Juranka P. F., Surujballi J. A., Brannigan G., and Baenziger J. E. (2015) Role of the fourth transmembrane α helix in the allosteric modulation of pentameric ligand-gated ion channels. Structure 23, 1655–1664 10.1016/j.str.2015.06.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Lee W.-Y., and Sine S. M. (2005) Principal pathway coupling agonist binding to channel gating in nicotinic receptors. Nature 438, 243–247 10.1038/nature04156 [DOI] [PubMed] [Google Scholar]
  • 33. Grutter T., de Carvalho L. P., Dufresne V., Taly A., Edelstein S. J., and Changeux J.-P. (2005) Molecular tuning of fast gating in pentameric ligand-gated ion channels. Proc. Natl. Acad. Sci. U S A 102, 18207–18212 10.1073/pnas.0509024102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Lummis S. C. R., Beene D. L., Lee L. W., Lester H. A., Broadhurst R. W., and Dougherty D. A. (2005) Cis–trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 438, 248–252 10.1038/nature04130 [DOI] [PubMed] [Google Scholar]
  • 35. Jha A., Cadugan D. J., Purohit P. G., and Auerbach A. (2007) Acetylcholine receptor gating at extracellular transmembrane domain interface: the cys-loop and M2-M3 linker. J. Gen. Physiol. 130, 547–558 10.1085/jgp.200709856 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Hénault C. M., Juranka P. F., and Baenziger J. E. (2015) The M4 transmembrane α-helix contributes differently to both the maturation and function of two prokaryotic pentameric ligand-gated ion channels. J. Biol. Chem. 290, 25118–25128 10.1074/jbc.M115.676833 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Alcaino C., Musgaard M., Minguez T., Mazzaferro S., Faundez M., Iturriaga-Vasquez P., Biggin P. C., and Bermudez I. (2017) Role of the cys loop and transmembrane domain in the allosteric modulation of α4β2 nicotinic acetylcholine receptors. J. Biol. Chem. 292, 551–562 10.1074/jbc.M116.751206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Butler A. S., Lindesay S. A., Dover T. J., Kennedy M. D., Patchell V. B., Levine B. A., Hope A. G., and Barnes N. M. (2009) Importance of the C-terminus of the human 5-HT3A receptor subunit. Neuropharmacology 56, 292–302 10.1016/j.neuropharm.2008.08.017 [DOI] [PubMed] [Google Scholar]
  • 39. Cory-Wright J., Alqazzaz M. A., Wroe F., Jeffreys J., Zhou L., and Lummis S. C. R. (2018) Aromatic residues in the fourth transmembrane-spanning helix M4 are important for GABAρ receptor function. ACS Chem. Neurosci. 9, 284–290 10.1021/acschemneuro.7b00315 [DOI] [PubMed] [Google Scholar]
  • 40. Pons S., Sallette J., Bourgeois J. P., Taly A., Changeux J.-P., and Devillers-Thiéry A. (2004) Critical role of the C-terminal segment in the maturation and export to the cell surface of the homopentameric α7-5HT3A receptor. Eur. J. Neurosci. 20, 2022–2030 10.1111/j.1460-9568.2004.03673.x [DOI] [PubMed] [Google Scholar]
  • 41. Hosie A. M., Wilkins M. E., da Silva H. M. A., and Smart T. G. (2006) Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444, 486–489 10.1038/nature05324 [DOI] [PubMed] [Google Scholar]
  • 42. Paradiso K., Zhang J., and Steinbach J. H. (2001) The C terminus of the human nicotinic α4β2 receptor forms a binding site required for potentiation by an estrogenic steroid. J. Neurosci. 21, 6561–6568 10.1523/JNEUROSCI.21-17-06561.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Domville J. A., and Baenziger J. E. (2018) An allosteric link connecting the lipid-protein interface to the gating of the nicotinic acetylcholine receptor. Sci. Rep. 8, 3898 10.1038/s41598-018-22150-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Haeger S., Kuzmin D., Detro-Dassen S., Lang N., Kilb M., Tsetlin V., Betz H., Laube B., and Schmalzing G. (2010) An intramembrane aromatic network determines pentameric assembly of Cys-loop receptors. Nat. Struct. Mol. Biol. 17, 90–98 10.1038/nsmb.1721 [DOI] [PubMed] [Google Scholar]
  • 45. Tang B., and Lummis S. C. R. (2018) The roles of aromatic residues in the glycine receptor transmembrane domain. BMC Neurosci. 19, 53 10.1186/s12868-018-0454-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Mesoy S., Jeffreys J., and Lummis S. C. R. (2019) Characterization of residues in the 5-HT3 receptor M4 region that contribute to function. ACS Chem. Neurosci. 10, 3167–3172 10.1021/acschemneuro.8b00603 [DOI] [PubMed] [Google Scholar]
  • 47. Da Costa Couto A. R. G. M., Price K. L., Mesoy S., Capes E., and Lummis S. C. R. (2020) The M4 helix is involved in α7 nACh receptor function. ACS Chem. Neurosci. 11, 1406–1412 10.1021/acschemneuro.0c00027 [DOI] [PubMed] [Google Scholar]
  • 48. Unwin N. (2005) Refined structure of the nicotinic acetylcholine receptor at 4 Å resolution. J. Mol. Biol. 346, 967–989 10.1016/j.jmb.2004.12.031 [DOI] [PubMed] [Google Scholar]
  • 49. Newcombe J., Chatzidaki A., Sheppard T. D., Topf M., and Millar N. S. (2018) Diversity of nicotinic acetylcholine receptor positive allosteric modulators revealed by mutagenesis and a revised structural model. Mol. Pharmacol. 93, 128–140 10.1124/mol.117.110551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Mnatsakanyan N., and Jansen M. (2013) Experimental determination of the vertical alignment between the second and third transmembrane segments of muscle nicotinic acetylcholine receptors. J. Neurochem. 125, 843–854 10.1111/jnc.12260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Blanton M. P., and Cohen J. B. (1992) Mapping the lipid-exposed regions in the Torpedo californica nicotinic acetylcholine receptor. Biochemistry 31, 3738–3750 10.1021/bi00130a003 [DOI] [PubMed] [Google Scholar]
  • 52. Morales-Perez C. L., Noviello C. M., and Hibbs R. E. (2016) X-ray structure of the human 42 nicotinic receptor. Nature 538, 411–415 10.1038/nature19785 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Walsh R. M., Roh S.-H., Gharpure A., Morales-Perez C. L., Teng J., and Hibbs R. E. (2018) Structural principles of distinct assemblies of the human α4β2 nicotinic receptor. Nature 557, 261–265 10.1038/s41586-018-0081-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Marks D. S., Colwell L. J., Sheridan R., Hopf T. A., Pagnani A., Zecchina R., and Sander C. (2011) Protein 3D structure computed from evolutionary sequence variation. PLoS ONE 6, e28766 10.1371/journal.pone.0028766 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Marks D. S., Hopf T. A., and Sander C. (2012) Protein structure prediction from sequence variation. Nat. Biotechnol. 30, 1072–1080 10.1038/nbt.2419 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Mitra A., Bailey T. D., and Auerbach A. (2004) Structural dynamics of the M4 transmembrane segment during acetylcholine receptor gating. Structure 12, 1909–1918 10.1016/j.str.2004.08.004 [DOI] [PubMed] [Google Scholar]
  • 57. Shen X.-M., Deymeer F., Sine S. M., and Engel A. G. (2006) Slow-channel mutation in acetylcholine receptor αM4 domain and its efficient knockdown. Ann. Neurol. 60, 128–136 10.1002/ana.20861 [DOI] [PubMed] [Google Scholar]
  • 58. Daeffler K. N.-M., Lester H. A., and Dougherty D. A. (2012) Functionally important aromatic–aromatic and sulfur−π interactions in the D2 dopamine receptor. J. Am. Chem. Soc. 134, 14890–14896 10.1021/ja304560x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Therien J. P. D., and Baenziger J. E. (2017) Pentameric ligand-gated ion channels exhibit distinct transmembrane domain archetypes for folding/expression and function. Sci. Rep 7, 450 10.1038/s41598-017-00573-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Carswell C. L., Labriola J. M., and Baenziger J. E. (2013) Effects of lipids on the structure and function of GLIC and ELIC. Biophys. J. 104, 219a 10.1016/j.bpj.2012.11.1235 [DOI] [Google Scholar]
  • 61. Tamamizu S., Guzmán G. R., Santiago J., Rojas L. V., McNamee M. G., and Lasalde-Dominicci J. A. (2000) Functional effects of periodic tryptophan substitutions in the α M4 transmembrane domain of the Torpedo californica nicotinic acetylcholine receptor. Biochemistry 39, 4666–4673 10.1021/bi992835w [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Data Availability Statement

All data described here are available within the manuscript and supporting information.


Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES